HONOREE
Leigh Vosseller
Chief Financial Officer & EVP
Tandem Diabetes Care
Leigh Vosseller began her career in public accounting at Deloitte and has continued to develop her financial skills and expertise over the last 20 years at various companies in biotech and life sciences in the San Diego area. She currently serves as Tandem Diabetes Care, Inc.’s executive vice president, chief financial officer, and treasurer since June 2018. Tandem is a mission-driven organization dedicated to improving the lives of people with diabetes through a portfolio of products and solutions.
In her current role at Tandem, Vosseller oversees the traditional finance and accounting functions, and also recently took on increased responsibility for the market access function. It is a pivotal time to lead this function at Tandem as the company is evaluating a transition from the traditional reimbursement channel for business model optimization. Since promotion into the CFO role in early 2018, the company has grown annual sales at a cumulative average growth rate of approximately 50% and increased the size of its customer base seven-fold as a result of a transformative new product launch and commencement of operations outside the United States. Vosseller has also successfully led the execution of three public financings, one of which was critical to the company’s ability to continue operations after a severe disruption in the market by a competitor put Tandem’s business in jeopardy. In the past 24 months, she has played a key leadership role as Tandem has grown at a CAGR of nearly 30% with continued expansion into markets outside the U.S., secured FDA approval, and launched a new product, navigated through the lingering effects of a challenging COVID environment, managed spending through a tough competitive and economic environment, and closed two acquisitions.
Vosseller previously served as vice president and chief financial officer at Genoptix Medical Laboratory in 2011 after initially joining Genoptix in 2008. Prior to that, she held a senior finance position at Biosite, Inc., where she played a key role in developing the company’s financial and administrative infrastructure.
Public Company: Large - Finalists
David Barter
Chief Financial Officer
New Relic
David Barter is New Relic’s chief financial officer and brings nearly three decades of high-growth public and private company finance experience to New Relic. Most recently, he served as chief financial officer of C3 AI, where he led the company through a successful IPO. Previously, he held the chief financial officer position at Model N and led finance teams at Microsoft, General Electric, and Guidewire Software.
Barter is an established business leader with proven success leading the financial strategies of public companies in the technology sector. He holds a master of business administration and master of engineering management from Northwestern University’s Kellogg School of Management, and a bachelor in business administration in finance and philosophy from University of Notre Dame.
Irene H. Oh
Chief Financial Officer & EVP
East West Bank
Irene H. Oh has served as executive vice president and chief financial officer of East West Bancorp and East West Bank since January 2010. She joined East West in 2004 and has held various leadership roles at the bank in accounting and corporate finance. Prior to joining East West, she held positions at Goldman Sachs and at Deloitte & Touche LLP.
Oh is a board member of PS Business Parks, Inc. and also serves on both the board and the audit committee of United Way of Greater Los Angeles. She received a bachelor's degree from California State University, Los Angeles and a master's degree in accounting from the University of Southern California. Oh is also a certified public accountant.
Karsten Voermann
Chief Financial Officer
GoodRx
Karsten Voermann is GoodRx’s chief financial officer, bringing more than 20 years of experience at executive posts across a wide array of high-growth and profitable companies. His impressive professional background includes five previous positions as CFO, along with his commitment to fostering an empowering and learning-oriented environment that make him a valued leader at GoodRx.
Since joining GoodRx in February 2020, Voermann has significantly scaled the company’s financial operations, including resource allocation and implementation of key financial systems. He led GoodRx through its successful IPO in September 2020, raising over $1.1 billion in the biggest digital health public offering of the year, and has been instrumental in overseeing financial compliance and reporting as a publicly traded company and driving sustained financial growth year-over-year.
Christopher Young
Interim CEO, Chief Financial Officer & Treasurer
Entravision Communications
As CFO of Entravision, a leading global advertising solutions, media, and technology company, Chris Young has a unique background geared around finance and media operations than the typical accounting path of CFOs. He began his career as a banker and became CFO of Visa Media, a national Outdoor Advertising company, which was acquired by Entravision.
Upon arriving at Entravision, Young was quickly promoted to run the Outdoor Advertising division. Upon helping Entravision successfully divest its Outdoor division, in 2008 he moved into the role as CFO of the parent company. Since that time, he has leveraged his banking experience to help guide Entravision through multiple recessions and loan amendments while ensuring the company stayed focused on reducing its debt levels to nearly zero times on a net of cash basis.
